Researchers review a new synthesis of the existing evidence and conclude that the harms of antidepressants outweigh any benefits.
This piece is the second of a two-part essay about suicide, diagnosis, what doesn't help, and what does help. This part is about barriers to seeking help and about the ways we actually can be of help to people who are considering suicide.
This piece is the first of a two-part essay about suicide, diagnosis, what doesn't help, and what does help. This part is about suicide, diagnosis, and some of what fails to help.
A new review of strategies to support both patients and practitioners through the process of discontinuing antidepressants.
Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.
It seems more and more common for people who consider themselves mental health advocates to make the argument that “mental illness is like physical illness.” Have you heard this “depression is like diabetes” tactic? I have a hard time seeing how this is advocating for those in emotional distress.
The spurious chemical imbalance theory of depression is arguably the most destructive thing that psychiatry has ever done. Worldwide, millions of individuals are taking antidepressants, often with a cocktail of other drugs, because they have been told the blatant falsehood that they need the pills to combat a brain illness.
Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
In a new study, researchers found no evidence of antidepressant group variance, which means that there's no particular group of patients who improve more than others on the drug.
A review of 73 antidepressant studies finds that 12% more people drop out of clinical trials when taking antidepressants than when taking placebo, evidence that many find the adverse effects of antidepressants difficult to tolerate.
In a new study published in JAMA Psychiatry, researchers investigated whether they could use EEG (electroencephalograph) technology to predict whether people would feel better...
In-depth interviews find that those who screened positive for depression did not explain their experience in terms of diagnostic symptoms.
A network analysis of participants’ social media use and well-being reveals complex links with social capital but a minimal association with attentional control.
Ayahuasca found to be effective in treating moderate to severe depression in low-income population.
An issue of Lancet Psychiatry is devoted to clarifying the lack of efficacy for Zoloft (sertraline).
Young women’s narratives indicate ways antidepressants have shaped their sense of self.
Researchers compared the efficacy of antidepressants using different rating scales and found them to be no different—just slightly better than placebo, and not meeting the criteria for clinical significance.
A new study finds poorer depression and anxiety outcomes in psychotherapy for people in economically deprived neighborhoods and those on antidepressants.
The use of antidepressants has risen quickly among older adults but the rate of depressive symptoms in this population has not declined as a result.
A Nigerian study finds that more than three-quarters of patients improved, even when only 13% were prescribed medication.